Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances

Before the COVID‐19 pandemic, common community‐acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well‐being of allogeneic hematopoietic cell transplant (allo‐HCT) recipients, often resulting in severe illness and even death. The pandemic has further highlighte...

Full description

Saved in:
Bibliographic Details
Published inTransplant infectious disease Vol. 25; no. S1; pp. e14117 - n/a
Main Authors Piñana, Jose L., Pérez, Ariadna, Chorão, Pedro, Guerreiro, Manuel, García‐Cadenas, Irene, Solano, Carlos, Martino, Rodrigo, Navarro, David
Format Journal Article
LanguageEnglish
Published Denmark Wiley Subscription Services, Inc 01.11.2023
Subjects
Online AccessGet full text
ISSN1398-2273
1399-3062
1399-3062
DOI10.1111/tid.14117

Cover

Abstract Before the COVID‐19 pandemic, common community‐acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well‐being of allogeneic hematopoietic cell transplant (allo‐HCT) recipients, often resulting in severe illness and even death. The pandemic has further highlighted the significant risk that immunosuppressed patients, including allo‐HCT recipients, face when infected with SARS‐CoV‐2. As preventive transmission measures are relaxed and CARVs circulate again among the community, including in allo‐HSCT recipients, it is crucial to understand the current state of knowledge, gaps, and recent advances regarding CARV infection in allo‐HCT recipients. Urgent research is needed to identify seasonal respiratory viruses as potential drivers for future pandemics.
AbstractList Before the COVID-19 pandemic, common community-acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well-being of allogeneic hematopoietic cell transplant (allo-HCT) recipients, often resulting in severe illness and even death. The pandemic has further highlighted the significant risk that immunosuppressed patients, including allo-HCT recipients, face when infected with SARS-CoV-2. As preventive transmission measures are relaxed and CARVs circulate again among the community, including in allo-HSCT recipients, it is crucial to understand the current state of knowledge, gaps, and recent advances regarding CARV infection in allo-HCT recipients. Urgent research is needed to identify seasonal respiratory viruses as potential drivers for future pandemics.
Before the COVID-19 pandemic, common community-acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well-being of allogeneic hematopoietic cell transplant (allo-HCT) recipients, often resulting in severe illness and even death. The pandemic has further highlighted the significant risk that immunosuppressed patients, including allo-HCT recipients, face when infected with SARS-CoV-2. As preventive transmission measures are relaxed and CARVs circulate again among the community, including in allo-HSCT recipients, it is crucial to understand the current state of knowledge, gaps, and recent advances regarding CARV infection in allo-HCT recipients. Urgent research is needed to identify seasonal respiratory viruses as potential drivers for future pandemics.Before the COVID-19 pandemic, common community-acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well-being of allogeneic hematopoietic cell transplant (allo-HCT) recipients, often resulting in severe illness and even death. The pandemic has further highlighted the significant risk that immunosuppressed patients, including allo-HCT recipients, face when infected with SARS-CoV-2. As preventive transmission measures are relaxed and CARVs circulate again among the community, including in allo-HSCT recipients, it is crucial to understand the current state of knowledge, gaps, and recent advances regarding CARV infection in allo-HCT recipients. Urgent research is needed to identify seasonal respiratory viruses as potential drivers for future pandemics.
Author Navarro, David
García‐Cadenas, Irene
Piñana, Jose L.
Martino, Rodrigo
Solano, Carlos
Chorão, Pedro
Pérez, Ariadna
Guerreiro, Manuel
Author_xml – sequence: 1
  givenname: Jose L.
  orcidid: 0000-0001-8533-2562
  surname: Piñana
  fullname: Piñana, Jose L.
  email: jlpinana@gmail.com
  organization: Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia
– sequence: 2
  givenname: Ariadna
  surname: Pérez
  fullname: Pérez, Ariadna
  organization: Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia
– sequence: 3
  givenname: Pedro
  orcidid: 0000-0001-6741-971X
  surname: Chorão
  fullname: Chorão, Pedro
  organization: Hospital Universitário y Politécncio La Fe
– sequence: 4
  givenname: Manuel
  surname: Guerreiro
  fullname: Guerreiro, Manuel
  organization: Hospital Universitário y Politécncio La Fe
– sequence: 5
  givenname: Irene
  surname: García‐Cadenas
  fullname: García‐Cadenas, Irene
  organization: Hospital de la Santa Creu i Sant Pau
– sequence: 6
  givenname: Carlos
  surname: Solano
  fullname: Solano, Carlos
  organization: Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia
– sequence: 7
  givenname: Rodrigo
  surname: Martino
  fullname: Martino, Rodrigo
  organization: Hospital de la Santa Creu i Sant Pau
– sequence: 8
  givenname: David
  orcidid: 0000-0003-3010-4110
  surname: Navarro
  fullname: Navarro, David
  organization: School of Medicine, University of Valencia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37585370$$D View this record in MEDLINE/PubMed
BookMark eNp1kV1rHCEYhaWkNMm2F_0DRehNC5nEj51Re1c2_QgECiW9FkffWUxndapOwl73j8fNbm5C64WKPOfwes4pOgoxAEJvKTmndV0U787pklLxAp1QrlTDSceOHu-yYUzwY3Sa8y0hVKileoWOuWhlywU5QX9_Qp58MiWmLb7zac7YhwFs8TFkbIYCCZtxjGsI4C3OBTbYwjjikkzI02hCMTv2E17NKUEoeA4OUi4mOB_WZ_h3iPcjuDXgtZnyGa7vOIHdkcbdmWAhv0YvBzNmeHM4F-jX1y83q-_N9Y9vV6vP143lddhGcco6wdu-5SCWlopOGeP6XhDZ9oR3qlNiYHJY9iCdJNJZQZyTTDFqjZCOL9CHve-U4p8ZctEbn3efMQHinDWTLes4k3VboPfP0Ns4p1Cnq5RSlakRVurdgZr7DTg9Jb8xaauf4q3AxR6wKeacYNDW7_Oq8flRU6J3BepaoH4ssCo-PlM8mf6LPbjf-xG2_wf1zdXlXvEAejCrTQ
CitedBy_id crossref_primary_10_1038_s41409_025_02536_y
crossref_primary_10_3389_fonc_2024_1389345
crossref_primary_10_1097_MD_0000000000041683
crossref_primary_10_1093_cid_ciae602
crossref_primary_10_2147_IDR_S427762
crossref_primary_10_1007_s15010_024_02213_0
crossref_primary_10_1038_s41409_024_02304_4
crossref_primary_10_1016_j_jtct_2025_02_012
crossref_primary_10_1016_j_retram_2024_103461
Cites_doi 10.1016/S0140-6736(22)02597-1
10.1128/JCM.00789-11
10.1097/01.md.0000232560.22098.4e
10.1093/jac/dkt111
10.1016/j.bbmt.2009.06.019
10.1016/j.cmi.2020.11.004
10.1016/j.ccm.2016.11.010
10.1371/journal.pone.0271756
10.1016/j.bbmt.2012.12.019
10.1086/598627
10.1093/cid/ciy584
10.1016/j.bbmt.2018.08.021
10.1093/infdis/jiz656
10.1093/cid/cit639
10.1016/j.canlet.2016.05.035
10.1097/COH.0000000000000794
10.1128/AAC.00766-18
10.1002/ajh.26385
10.1182/blood-2002-02-0377
10.1128/jcm.01785-21
10.1164/rccm.200212‐1468OC
10.1016/S2213‐2600(22)00412‐X
10.1056/NEJMoa2001282
10.1111/tid.13276
10.3324/haematol.2018.215152
10.3390/ijms24054847
10.1016/j.canlet.2015.11.014
10.1111/tid.13301
10.1016/S0140-6736(22)00519-0
10.1016/j.bbmt.2013.05.005
10.1093/cid/ciu623
10.1056/NEJMoa2208822
10.1128/JCM.00367-18
10.7883/yoken.JJID.2017.424
10.1016/j.bbmt.2016.07.005
10.1182/blood‐2010‐11‐319186
10.1038/s41598-021-02972-y
10.1016/S2213-2600(16)30435-0
10.18632/oncotarget.10182
10.1016/j.bbmt.2015.11.015
10.1016/j.cmi.2021.11.007
10.1186/s13045-022-01250-2
10.1086/344899
10.1164/rccm.200604-489OC
10.1093/cid/ciy760
10.1128/CMR.00116-13
10.1002/cpt.2646
10.1111/tid.13415
10.1016/S1473-3099(14)70717-0
10.1016/j.cmi.2015.12.012
10.3324/haematol.2014.116772
10.1111/bjh.16216
10.1016/j.bbmt.2005.07.007
10.1016/S0140-6736(20)32013-4
10.1038/bmt.2008.264
10.1016/j.bbmt.2019.12.724
10.1038/s41375-021-01302-5
10.1093/cid/ciaa1764
10.1038/s41375‐021‐01302‐5
10.1002/jmv.21548
10.1093/infdis/jiaa553
10.1182/blood‐2021‐147274
10.1016/j.bbmt.2010.07.018
10.1056/NEJMsb2104756
10.1016/j.bbmt.2012.04.012
10.1038/bmt.2017.24
10.1093/cid/ciw284
10.1056/NEJMoa2031994
10.3389/fmicb.2018.02478
10.1182/bloodadvances.2020003865
10.1371/journal.pone.0148258
10.1038/s41408-022-00778-3
10.1038/sj.bmt.1703139
10.1002/iid3.502
10.1093/jac/dkab243
10.1080/10428194.2018.1468896
10.3390/v14020267
10.1093/cid/ciaa1149
10.1093/infdis/jiy547
10.1016/j.cmi.2019.10.012
10.1086/422994
10.1128/JCM.02151‐12
10.3324/haematol.2022.281946
10.1038/bmt.2013.94
10.3390/microorganisms10091856
10.1016/j.bbmt.2009.09.014
10.1183/13993003.03725-2020
10.1093/cid/ciab371
10.1007/s00705‐013‐1610‐1
10.1128/JCM.02264-16
10.1186/s40164‐020‐00177‐z
10.1038/sj.bmt.1703083
10.1016/j.jtct.2022.09.002
10.1093/cid/ciac312
10.1093/infdis/jiab391
10.1111/irv.12972
10.1016/j.coviro.2016.01.016
10.1056/NEJMoa2116044
10.1111/tid.13158
10.1182/blood.V98.3.573
10.3389/fphar.2021.683296
10.1038/s41564-022-01143-7
10.1111/bjh.17651
10.1086/432732
10.1016/S1473-3099(21)00485-0
10.1038/s41409-019-0728-5
10.1097/INF.0b013e3181f12fcf
10.1086/525263
10.1093/infdis/jix358
10.1038/s41409‐019‐0698‐7
10.1016/j.bbmt.2017.11.001
10.1016/j.idc.2019.02.004
10.7326/0003-4819-144-5-200603070-00010
10.1093/infdis/jiad268
10.1016/j.bbmt.2012.10.014
10.1128/JCM.06579-11
10.1038/bmt.2009.78
10.1038/s41408‐022‐00778‐3
10.1056/NEJMoa2106062
10.1056/NEJMoa2033130
10.1016/j.healun.2007.05.020
10.1016/j.jinf.2019.12.022
10.1016/S1473-3099(09)70175-6
10.3201/eid1309.070318
10.1182/blood-2009-11-255455
10.1111/tid.12111
10.3324/haematol.2016.153767
10.1093/cid/cis844
10.1111/tid.12926
10.1038/s41598-021-97700-x
10.1111/j.1365-2141.2006.06108.x
10.1086/375069
10.1182/blood.2022016202
10.1016/j.cmi.2022.04.018
10.1111/tid.12729
10.1016/j.bbmt.2009.12.534
10.1038/s41409‐023‐01946‐0
10.1016/j.bbmt.2018.07.006
10.1007/s40121-019-00271-8
10.1128/JCM.01816-15
10.1038/sj.bmt.1705781
10.1182/blood-2009-09-244152
10.1016/S2213-2600(21)00331-3
10.1016/j.bbmt.2018.12.005
10.3389/fimmu.2023.1125824
10.1128/CMR.00010‐16
10.1128/JVI.01659-16
10.1186/s12916-022-02518-7
10.1016/j.bbmt.2018.05.016
10.1111/tid.12167
10.1128/JCM.39.2.801-803.2001
10.1038/s41409‐020‐0943‐0
10.1038/s41409‐021‐01319‐5
10.1016/S0140‐6736(21)01594‐4
10.1093/infdis/jix264
10.3324/haematol.2018.206896
10.1038/s41409‐021‐01462‐z
10.1016/j.jcv.2015.04.012
10.1093/cid/civ272
10.1093/cid/ciu134
10.1086/504268
10.1056/NEJMc2031364
10.14745/ccdr.v47i03a02
10.1111/j.1399‐3062.2008.00362.x
10.1186/s13045‐022‐01275‐7
10.1016/j.bbmt.2018.03.004
10.1182/blood‐2011‐08‐371112
10.1002/rmv.2375
10.1016/j.cmi.2021.05.020
10.1093/cid/ciy874
10.3109/10428194.2015.1113279
10.1093/cid/ciy792
10.1007/s40291-022-00580-8
10.1128/JVI.01631‐14
10.3390/v13081665
10.1016/j.bbmt.2012.11.139
10.1093/infdis/jit832
10.1093/infdis/jis610
10.1182/blood-2006-12-060343
10.1002/jmv.28471
10.1111/tid.12054
10.1016/j.jcv.2022.105152
10.1093/infdis/jix203
10.1093/cid/cix160
10.1111/tid.12022
10.1016/j.diagmicrobio.2015.10.025
10.1111/j.1365-2141.2009.07654.x
10.1086/425004
10.1111/ejh.12094
10.1016/j.bbmt.2018.11.022
10.1016/j.ccell.2022.02.012
10.3109/10428194.2015.1067699
10.1056/NEJMc2031670
10.1128/aac.00452-22
10.1182/blood-2003-05-1425
10.1182/blood‐2022‐167773
10.1016/j.cmi.2017.11.018
10.1038/s41409‐022‐01575‐z
10.1128/cmr.00168-21
10.1182/bloodadvances.2021004915
10.3389/fimmu.2018.00678
10.1093/infdis/jiab611
10.1007/s00134-021-06448-5
10.1182/blood-2010-11-319186
10.1016/S1473-3099(20)30004-9
10.1097/QCO.0b013e3283480440
10.1111/tid.13792
10.1093/jac/dkab245
10.1007/s15010-012-0279-9
10.1182/blood-2013-12-541359
10.3324/haematol.2021.280407
10.1111/tid.13602
10.1016/j.ijid.2023.03.045
10.1093/infdis/jiac135
10.1093/ofid/ofy077
10.1038/s41409‐022‐01790‐8
10.1038/s41409‐018‐0386‐z
10.1038/sj.bmt.1704359
10.1016/S1473‐3099(18)30600‐5
10.1128/spectrum.00503-22
10.1016/j.bbmt.2010.09.014
ContentType Journal Article
Copyright 2023 Wiley Periodicals LLC.
Copyright_xml – notice: 2023 Wiley Periodicals LLC.
CorporateAuthor the Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC)
Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC)
CorporateAuthor_xml – name: the Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC)
– name: Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC)
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7U9
8FD
FR3
H94
K9.
M7N
P64
7X8
DOI 10.1111/tid.14117
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Virology and AIDS Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Biotechnology Research Abstracts
Technology Research Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Virology and AIDS Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1399-3062
EndPage n/a
ExternalDocumentID 37585370
10_1111_tid_14117
TID14117
Genre reviewArticle
Journal Article
Review
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1OC
29Q
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
YFH
YUY
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7U9
8FD
FR3
H94
K9.
M7N
P64
7X8
ID FETCH-LOGICAL-c3537-93126735b53e74c1769aadbb7085b0369697f28f4be8d808dc70dd82921ca78d3
IEDL.DBID DR2
ISSN 1398-2273
1399-3062
IngestDate Wed Oct 01 13:43:46 EDT 2025
Fri Jul 25 23:17:58 EDT 2025
Mon Jul 21 06:01:06 EDT 2025
Wed Oct 01 02:09:33 EDT 2025
Thu Apr 24 23:03:49 EDT 2025
Wed Jan 22 16:15:18 EST 2025
IsPeerReviewed true
IsScholarly true
Issue S1
Keywords respiratory virus
rhinovirus
COVID-19
community acquired respiratory virus (CARV)
SARS-CoV-2
allogeneic stem cell transplantation
vaccines.VRS
adenovirus
influenza virus
human adenovirus
human parainfluenza virus
human metapneumovirus
human seasonal coronavirus
human bocavirus
Language English
License 2023 Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3537-93126735b53e74c1769aadbb7085b0369697f28f4be8d808dc70dd82921ca78d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0001-8533-2562
0000-0001-6741-971X
0000-0003-3010-4110
PMID 37585370
PQID 2899282375
PQPubID 1096379
PageCount 22
ParticipantIDs proquest_miscellaneous_2852632826
proquest_journals_2899282375
pubmed_primary_37585370
crossref_citationtrail_10_1111_tid_14117
crossref_primary_10_1111_tid_14117
wiley_primary_10_1111_tid_14117_TID14117
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2023
2023-11-00
2023-Nov
20231101
PublicationDateYYYYMMDD 2023-11-01
PublicationDate_xml – month: 11
  year: 2023
  text: November 2023
PublicationDecade 2020
PublicationPlace Denmark
PublicationPlace_xml – name: Denmark
– name: Malden
PublicationTitle Transplant infectious disease
PublicationTitleAlternate Transpl Infect Dis
PublicationYear 2023
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2010; 16
2011; 117
2009; 81
2020; 20
2013; 68
2006; 174
2014; 27
2022; 24
2019; 19
2022; 26
2012; 18
2022; 20
2022; 22
2012; 14
2009;; 11
2021; 73
2022; 28
2004; 33
2018; 9
2021; 76
2018; 5
2023; 67
2021; 398
2013; 57
2013; 56
2004; 39
2022; 40
2019; 21
2013; 51
2010; 115
2019; 25
2014; 16
2022; 35
2014; 14
2022; 32
2003; 168
2009; 15
2014; 123
2021; 47
2019; 8
2022; 112
2005; 192
2017; 64
2020; 383
2020; 382
2019; 33
1999; 29
2015; 53
2019; 104
2003; 36
2013; 90
2021; 384
2001; 28
2021; 385
2006; 193
2016; 16
2018; 20
2007; 13
2018; 24
2016; 11
2012; 50
2021; 58
2015; 68
2016; 7
2017; 52
2021; 56
2022; 150‐151
2020; 396
2022; 6
2015; 61
2017; 55
2022; 7
2021; 138
2022; 14
2020; 26
2008; 46
2022; 15
2019; 219
2022; 97
2020; 22
2022; 10
2001; 39
2008; 42
2022; 108
2022; S2213‐2600
2022; 107
2005; 11
2022; 16
2022; 225
2012; 119
2022; 17
2022; 226
2016; 22
2012; 40
2017; 5
2009; 44
2021; 27
2021; 23
2023; 141
2019; 54
2023; 388
2015; 100
2023; S1201‐9712
2023; 1
2020; 55
2011; 17
2012; 206
2006; 134
2013; 19
2021; 35
2017; 30
2023; 24
2013; 15
2019; 60
2014; 209
2017; 38
2019; 68
2002; 100
2020; 9
2014; 59
2021; 195
2014; 58
2013; 158
2016; 84
2011; 24
2022; 75
2018; 71
2007; 26
2005; 35
2001; 98
2021; 9
2023; 95
2023; 13
2013; 48
2021; 5
2023; 14
2004; 103
2021; 223
2023; 18
2020; 80
2011; 30
2020; 105
2023; 401
2020; 188
2020; 221
2018; 62
2018; 67
2016; 57
2014; 88
2017; 216
2022; 399
2022; 386
2021; 13
2022; 140
2006; 85
2012; 2
2017; 91
2021; 12
2021; 11
2023
2022; 60
2022
2023; 195
2020
2007; 110
2022; 57
2016; 63
2009; 9
2009; 145
2017; 19
2016; 379
2007; 40
2018; 56
2011; 49
2017; 102
2006; 144
2016; 370
e_1_2_16_23_1
e_1_2_16_46_1
e_1_2_16_222_1
e_1_2_16_69_1
Shah DP (e_1_2_16_150_1) 2012; 2
e_1_2_16_113_1
e_1_2_16_136_1
e_1_2_16_159_1
e_1_2_16_84_1
e_1_2_16_61_1
e_1_2_16_101_1
e_1_2_16_162_1
e_1_2_16_185_1
e_1_2_16_234_1
e_1_2_16_219_1
e_1_2_16_19_1
e_1_2_16_34_1
e_1_2_16_57_1
e_1_2_16_210_1
e_1_2_16_233_1
e_1_2_16_11_1
e_1_2_16_109_1
e_1_2_16_124_1
e_1_2_16_147_1
e_1_2_16_95_1
e_1_2_16_72_1
e_1_2_16_9_1
e_1_2_16_112_1
e_1_2_16_196_1
e_1_2_16_173_1
e_1_2_16_207_1
e_1_2_16_45_1
e_1_2_16_68_1
Pagano L (e_1_2_16_183_1) 2022
e_1_2_16_200_1
e_1_2_16_22_1
e_1_2_16_60_1
e_1_2_16_83_1
e_1_2_16_114_1
e_1_2_16_137_1
e_1_2_16_186_1
e_1_2_16_163_1
e_1_2_16_212_1
e_1_2_16_18_1
e_1_2_16_56_1
e_1_2_16_211_1
e_1_2_16_79_1
e_1_2_16_33_1
e_1_2_16_102_1
e_1_2_16_71_1
e_1_2_16_94_1
e_1_2_16_10_1
e_1_2_16_125_1
e_1_2_16_148_1
e_1_2_16_8_1
e_1_2_16_197_1
e_1_2_16_151_1
e_1_2_16_174_1
e_1_2_16_223_1
e_1_2_16_208_1
e_1_2_16_29_1
e_1_2_16_67_1
e_1_2_16_220_1
e_1_2_16_119_1
e_1_2_16_44_1
Schwartz K (e_1_2_16_131_1) 2023; 195
e_1_2_16_21_1
e_1_2_16_157_1
e_1_2_16_82_1
e_1_2_16_122_1
e_1_2_16_145_1
e_1_2_16_160_1
e_1_2_16_217_1
e_1_2_16_17_1
e_1_2_16_78_1
e_1_2_16_231_1
e_1_2_16_32_1
e_1_2_16_55_1
Tol MJ (e_1_2_16_192_1) 2005; 35
e_1_2_16_70_1
e_1_2_16_107_1
e_1_2_16_168_1
e_1_2_16_93_1
e_1_2_16_110_1
e_1_2_16_156_1
e_1_2_16_133_1
e_1_2_16_3_1
e_1_2_16_171_1
e_1_2_16_194_1
e_1_2_16_205_1
e_1_2_16_228_1
e_1_2_16_221_1
e_1_2_16_28_1
e_1_2_16_89_1
e_1_2_16_2_1
e_1_2_16_43_1
e_1_2_16_66_1
e_1_2_16_135_1
e_1_2_16_20_1
e_1_2_16_81_1
e_1_2_16_158_1
Grundeis F (e_1_2_16_140_1) 2023; 1
e_1_2_16_123_1
e_1_2_16_100_1
e_1_2_16_184_1
e_1_2_16_161_1
e_1_2_16_218_1
e_1_2_16_39_1
e_1_2_16_232_1
e_1_2_16_16_1
e_1_2_16_31_1
e_1_2_16_77_1
e_1_2_16_54_1
e_1_2_16_108_1
e_1_2_16_146_1
e_1_2_16_92_1
e_1_2_16_169_1
e_1_2_16_111_1
e_1_2_16_134_1
e_1_2_16_195_1
e_1_2_16_172_1
e_1_2_16_206_1
e_1_2_16_229_1
e_1_2_16_27_1
e_1_2_16_117_1
e_1_2_16_42_1
e_1_2_16_88_1
e_1_2_16_65_1
e_1_2_16_120_1
e_1_2_16_143_1
e_1_2_16_166_1
e_1_2_16_189_1
e_1_2_16_80_1
e_1_2_16_181_1
e_1_2_16_215_1
e_1_2_16_15_1
e_1_2_16_38_1
e_1_2_16_30_1
e_1_2_16_53_1
e_1_2_16_76_1
e_1_2_16_99_1
e_1_2_16_105_1
e_1_2_16_128_1
e_1_2_16_91_1
e_1_2_16_177_1
e_1_2_16_154_1
e_1_2_16_5_1
Centers for Disease Control and Prevention (e_1_2_16_37_1) 2020
e_1_2_16_226_1
e_1_2_16_203_1
e_1_2_16_26_1
e_1_2_16_49_1
e_1_2_16_41_1
e_1_2_16_64_1
e_1_2_16_87_1
e_1_2_16_118_1
e_1_2_16_179_1
e_1_2_16_121_1
e_1_2_16_167_1
e_1_2_16_144_1
e_1_2_16_182_1
e_1_2_16_216_1
e_1_2_16_14_1
e_1_2_16_230_1
e_1_2_16_98_1
e_1_2_16_52_1
e_1_2_16_129_1
e_1_2_16_75_1
e_1_2_16_106_1
e_1_2_16_90_1
e_1_2_16_132_1
e_1_2_16_155_1
e_1_2_16_178_1
e_1_2_16_4_1
e_1_2_16_193_1
e_1_2_16_170_1
e_1_2_16_204_1
e_1_2_16_227_1
e_1_2_16_25_1
e_1_2_16_48_1
e_1_2_16_63_1
e_1_2_16_86_1
e_1_2_16_115_1
e_1_2_16_138_1
e_1_2_16_40_1
e_1_2_16_164_1
e_1_2_16_187_1
e_1_2_16_141_1
e_1_2_16_213_1
e_1_2_16_13_1
e_1_2_16_36_1
e_1_2_16_59_1
e_1_2_16_74_1
e_1_2_16_103_1
e_1_2_16_97_1
e_1_2_16_51_1
e_1_2_16_126_1
e_1_2_16_149_1
e_1_2_16_7_1
e_1_2_16_209_1
e_1_2_16_198_1
e_1_2_16_175_1
e_1_2_16_152_1
e_1_2_16_201_1
e_1_2_16_190_1
e_1_2_16_224_1
e_1_2_16_24_1
e_1_2_16_47_1
e_1_2_16_139_1
e_1_2_16_85_1
e_1_2_16_62_1
e_1_2_16_116_1
e_1_2_16_142_1
e_1_2_16_188_1
e_1_2_16_165_1
e_1_2_16_214_1
e_1_2_16_180_1
e_1_2_16_12_1
e_1_2_16_35_1
e_1_2_16_58_1
e_1_2_16_104_1
e_1_2_16_96_1
e_1_2_16_73_1
e_1_2_16_50_1
e_1_2_16_127_1
e_1_2_16_199_1
e_1_2_16_153_1
e_1_2_16_176_1
e_1_2_16_6_1
e_1_2_16_130_1
e_1_2_16_202_1
e_1_2_16_225_1
e_1_2_16_191_1
References_xml – volume: S1201‐9712
  start-page: 00124
  issue: 23
  year: 2023
  end-page: 8
  article-title: Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: a KSGCT multicenter analysis
  publication-title: Int J Infect Dis
– volume: 19
  start-page: S167
  year: 2013
  end-page: S168
  article-title: Human rhinovirus RNA detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality
  publication-title: Biol Blood Marrow Transplant
– volume: 9
  start-page: 493
  issue: 8
  year: 2009
  end-page: 504
  article-title: Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
  publication-title: Lancet Infect Dis
– volume: 49
  start-page: S30
  year: 2011
  end-page: S33
  article-title: The clinical microbiology laboratory in the diagnosis of lower respiratory tract infections
  publication-title: J Clin Microbiol
– volume: 9
  start-page: 21
  year: 2020
  article-title: Infectious complications subcommittee of the Spanish hematopoietic stem cell transplantation and cell therapy group (GETH). Risk factors and outcome of COVID‐19 in patients with hematological malignancies
  publication-title: Exp Hematol Oncol
– volume: 15
  start-page: 1143
  year: 2009
  end-page: 1238
  article-title: Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective
  publication-title: Biol Blood Marrow Transplant
– volume: 95
  year: 2023
  article-title: Nirmatrelvir‐ritonavir for the treatment of COVID‐19 patients: a systematic review and meta‐analysis
  publication-title: J Med Virol
– volume: 108
  start-page: 1840
  issue: 7
  year: 2022
  end-page: 1850
  article-title: Allogeneic, off‐the‐shelf, SARS‐CoV‐2‐specific T cells (ALVR109) for the treatment of COVID‐19 in high risk patients
  publication-title: Haematologica
– volume: 209
  start-page: 1195
  issue: 8
  year: 2014
  end-page: 1204
  article-title: Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease
  publication-title: J Infect Dis
– volume: 117
  start-page: 5050
  issue: 19
  year: 2011
  end-page: 5056
  article-title: Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients
  publication-title: Blood
– volume: 61
  start-page: 192
  issue: 2
  year: 2015
  end-page: 202
  article-title: Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant
  publication-title: Clin Infect Dis
– volume: 11
  issue: 2
  year: 2016
  article-title: Long‐term shedding of influenza virus, parainfluenza virus, respiratory syncytial virus and nosocomial epidemiology in patients with hematological disorders
  publication-title: PLoS One
– volume: 7
  start-page: 53930
  year: 2016
  end-page: 53940
  article-title: Virus infection facilitates the development of severe pneumonia in transplant patients with hematologic malignancies
  publication-title: Oncotarget
– volume: 383
  start-page: 2586
  issue: 26
  year: 2020
  end-page: 2588
  article-title: Shedding of viable SARS‐CoV‐2 after immunosuppressive therapy for cancer
  publication-title: N Engl J Med
– volume: 144
  start-page: 344
  year: 2006
  end-page: 349
  article-title: Brief communication: fatal human metapneumovirus infection in stem‐cell transplant recipients
  publication-title: Ann Intern Med
– volume: 55
  start-page: 773
  year: 2020
  end-page: 779
  article-title: Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant
  publication-title: Bone Marrow Transplant
– volume: 14
  start-page: 267
  issue: 2
  year: 2022
  article-title: Rhinovirus infections among hematopoietic stem cell transplant recipients: a pre‐transplant dilemma?
  publication-title: Viruses
– volume: 141
  start-page: 877
  issue: 8
  year: 2023
  end-page: 885
  article-title: Banking on virus‐specific T cells to fulfill the need for off‐the‐shelf cell therapies
  publication-title: Blood
– volume: 58
  year: 2021
  article-title: Early use of nitazoxanide in mild COVID‐19 disease: randomised, placebo‐controlled trial
  publication-title: Eur Respir J
– volume: 13
  start-page: 1425
  year: 2007
  end-page: 1427
  article-title: Disseminated bocavirus infection after stem cell transplant
  publication-title: Emerg Infect Dis
– volume: 115
  start-page: 2088
  issue: 10
  year: 2010
  end-page: 2094
  article-title: Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients
  publication-title: Blood
– volume: 33
  start-page: 523
  issue: 2
  year: 2019
  end-page: 544
  article-title: Respiratory virus infections of the stem cell transplant recipient and the hematologic malignancy patient
  publication-title: Infect Dis Clin North Am
– volume: 56
  start-page: 258
  issue: 2
  year: 2013
  end-page: 266
  article-title: Fourth European Conference on Infections in Leukaemia (ECIL‐4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus
  publication-title: Clin Infect Dis
– volume: 24
  issue: 2
  year: 2022
  article-title: Impact of COVID‐19 in hematopoietic stem cell transplant recipients: a systematic review and meta‐analysis
  publication-title: Transpl Infect Dis
– volume: 370
  start-page: 358
  issue: 2
  year: 2016
  end-page: 364
  article-title: Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: a systematic review
  publication-title: Cancer Lett
– volume: 11
  issue: 1
  year: 2021
  article-title: Platinum chloride‐based viability RT‐qPCR for SARS‐CoV‐2 detection in complex samples
  publication-title: Sci Rep
– volume: 26
  start-page: 782
  issue: 4
  year: 2020
  end-page: 788
  article-title: Respiratory viruses cause late morbidity in recipients of hematopoietic stem cell transplantation
  publication-title: Biol Blood Marrow Transplant
– volume: 24
  start-page: 2293
  issue: 11
  year: 2018
  end-page: 2301
  article-title: Antibiotic exposure prior to respiratory viral infection is associated with progression to lower respiratory tract disease in allogeneic hematopoietic cell transplant recipients
  publication-title: Biol Blood Marrow Transplant
– volume: 22
  start-page: 1904
  year: 2016
  end-page: 1906
  article-title: Restrictive palivizumab use does not lead to increased morbidity and mortality in pediatric hematopoietic stem cell transplantation patients
  publication-title: Biol Blood Marrow Transplant
– volume: 28
  start-page: 479
  issue: 5
  year: 2001
  end-page: 484
  article-title: Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
  publication-title: Bone Marrow Transplant
– volume: 54
  start-page: 1058
  issue: 7
  year: 2019
  end-page: 1066
  article-title: Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients
  publication-title: Bone Marrow Transplant
– volume: 52
  start-page: 1016
  year: 2017
  end-page: 1021
  article-title: A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients
  publication-title: Bone Marrow Transplant
– volume: 40
  start-page: 677
  year: 2012
  end-page: 684
  article-title: Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation
  publication-title: Infection
– volume: 73
  start-page: e3884
  issue: 11
  year: 2021
  end-page: e3899
  article-title: Viral cultures for Coronavirus disease 2019 infectivity assessment: a systematic review
  publication-title: Clin Infect Dis
– volume: 84
  start-page: 304
  issue: 4
  year: 2016
  end-page: 308
  article-title: Evaluation of a fluorescent immunoassay rapid test (Sofia™) for detection of influenza A+B and RSV in a tertiary pediatric setting
  publication-title: Diagn Microbiol Infect Dis
– volume: 26
  start-page: 646
  year: 2020
  article-title: Early cidofovir administration might be associated with a lower probability of respiratory failure in treating human adenovirus pneumonia: a retrospective cohort study
  publication-title: Clin Microbiol Infect
– volume: 401
  start-page: 281
  year: 2023
  end-page: 293
  article-title: Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID‐19 at increased risk of adverse outcomes (PANORAMIC): an open‐label, platform‐adaptive randomised controlled trial
  publication-title: Lancet
– volume: 24
  start-page: 1490
  issue: 7
  year: 2018
  end-page: 1496
  article-title: Viral respiratory tract infections in allogeneic hematopoietic stem cell transplantation recipients in the era of molecular testing
  publication-title: Biol Blood Marrow Transplant
– volume: 57
  start-page: 623
  year: 2016
  end-page: 627
  article-title: Serious outbreak of human metapneumovirus in patients with hematologic malignancies
  publication-title: Leuk Lymphoma
– volume: 398
  start-page: 298
  issue: 10297
  year: 2021
  end-page: 299
  article-title: Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
  publication-title: Lancet
– volume: 24
  start-page: 1055
  issue: 10
  year: 2018
  end-page: 1063
  article-title: Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta‐analysis
  publication-title: Clin Microbiol Infect
– volume: 9
  start-page: 1197
  year: 2021
  end-page: 1208
  article-title: Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: a systematic review and meta‐analysis
  publication-title: Immun Inflamm Dis
– volume: 42
  start-page: 637
  issue: 10
  year: 2008
  end-page: 641
  article-title: Influenza vaccination in hematopoietic SCT recipients
  publication-title: Bone Marrow Transplant
– volume: 35
  start-page: 2885
  issue: 10
  year: 2021
  end-page: 2894
  article-title: COVID‐19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
  publication-title: Leukemia
– volume: 107
  start-page: 1731
  issue: 7
  year: 2022
  end-page: 1735
  article-title: Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID‐19
  publication-title: Haematologica
– volume: 63
  start-page: 178
  issue: 2
  year: 2016
  end-page: 185
  article-title: Human metapneumovirus infections following hematopoietic cell transplantation: factors associated with disease progression
  publication-title: Clin Infect Dis
– volume: 100
  start-page: e285
  year: 2015
  end-page: e288
  article-title: Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma
  publication-title: Haematologica
– volume: 386
  start-page: 1615
  year: 2022
  end-page: 1626
  article-title: Prefusion F protein‐based respiratory syncytial virus immunization in pregnancy
  publication-title: N Engl J Med
– volume: 22
  issue: 4
  year: 2020
  article-title: Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation
  publication-title: Transpl Infect Dis
– volume: 158
  start-page: 1297
  year: 2013
  end-page: 1303
  article-title: Influenza virus A(H1N1)pdm09 hemagglutinin polymorphism and associated disease in southern Germany during the 2010/11 influenza season
  publication-title: Arch Virol
– volume: 29
  start-page: 528
  year: 1999
  end-page: 532
  article-title: Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients
  publication-title: Clin Infect Dis
– volume: 22
  start-page: 209
  year: 2022
  end-page: 221
  article-title: Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID‐19 (DisCoVeRy): a phase 3, randomised, controlled, open‐label trial
  publication-title: Lancet Infect Dis
– volume: 225
  start-page: 2056
  year: 2022
  end-page: 2066
  article-title: Phase 1/2 randomized study of the immunogenicity, safety, and tolerability of a respiratory syncytial virus prefusion F vaccine in adults with concomitant inactivated influenza vaccine
  publication-title: J Infect Dis
– volume: 60
  issue: 2
  year: 2022
  article-title: Quantitative SARS‐CoV‐2 viral‐load curves in paired saliva samples and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection
  publication-title: J Clin Microbiol
– volume: 56
  start-page: e00367
  issue: 7
  year: 2018
  end-page: e00318
  article-title: Detection of influenza A and B viruses and respiratory syncytial virus by use of clinical laboratory improvement amendments of 1988 (CLIA)‐waived point‐of‐care assays: a paradigm shift to molecular tests
  publication-title: J Clin Microbiol
– volume: 195
  start-page: E220
  year: 2023
  end-page: E226
  article-title: Population‐based evaluation of the effectiveness of nirmatrelvir‐ritonavir for reducing hospital admissions and mortality from COVID‐19
  publication-title: Randomized Controlled Trial
– volume: 80
  start-page: 333
  issue: 3
  year: 2020
  end-page: 341
  article-title: The clinical benefit of instituting a prospective clinical community‐acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation
  publication-title: J Infect
– volume: 385
  start-page: 562
  issue: 6
  year: 2021
  end-page: 566
  article-title: SARS‐CoV‐2 variants in patients with immunosuppression
  publication-title: N Engl J Med
– volume: 27
  start-page: 472
  issue: 3
  year: 2021
  article-title: Field evaluation of a rapid antigen test (Panbio™ COVID‐19 Ag Rapid Test Device) for COVID‐19 diagnosis in primary healthcare centres
  publication-title: Clin Microbiol Infect
– volume: 40
  start-page: 343
  year: 2022
  end-page: 345
  article-title: Impact of COVID‐19 on case fatality rate of patients with cancer during the omicron wave
  publication-title: Cancer Cell
– volume: 216
  start-page: 678
  issue: 6
  year: 2017
  end-page: 687
  article-title: Immunologic profiling of human metapneumovirus for the development of targeted immunotherapy
  publication-title: J Infect Dis
– volume: 68
  start-page: 1641
  issue: 10
  year: 2019
  end-page: 1649
  article-title: Oral versus aerosolized ribavirin for the treatment of respiratory syncytial virus infections in hematopoietic cell transplant recipients
  publication-title: Clin Infect Dis
– volume: 62
  start-page: e00766
  year: 2018
  end-page: 18
  article-title: Orally efficacious broad‐spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses
  publication-title: Antimicrob Agents Chemother
– volume: 13
  start-page: 8
  issue: 1
  year: 2023
  article-title: One‐year breakthrough SARS‐CoV‐2 infection and correlates of protection in fully vaccinated hematological patients
  publication-title: Blood Cancer J
– volume: 5
  start-page: 1903
  issue: 7
  year: 2021
  end-page: 1914
  article-title: Risk factors for seasonal human coronavirus lower respiratory tract infection after hematopoietic cell transplantation
  publication-title: Blood Adv
– volume: 30
  start-page: 277
  issue: 1
  year: 2017
  end-page: 319
  article-title: Respiratory syncytial virus: infection, detection, and new options for prevention and treatment
  publication-title: Clin Microbiol Rev
– volume: 9
  start-page: 2478
  year: 2018
  article-title: Laboratory diagnosis of respiratory tract infections in children‐the state of the art
  publication-title: Front Microbiol
– volume: 57
  start-page: 649
  issue: 4
  year: 2022
  end-page: 657
  article-title: Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients
  publication-title: Bone Marrow Transplant
– volume: 8
  start-page: 613
  year: 2019
  end-page: 626
  article-title: Safety, resistance, and efficacy results from a phase IIIb study of conventional‐ and double‐dose oseltamivir regimens for treatment of influenza in immunocompromised patients
  publication-title: Infect Dis Ther
– volume: 53
  start-page: 3738
  year: 2015
  end-page: 3749
  article-title: Diagnostic accuracy of rapid antigen detection tests for respiratory syncytial virus infection: systematic review and meta‐analysis
  publication-title: J Clin Microbiol
– volume: 123
  start-page: 3263
  issue: 21
  year: 2014
  end-page: 3268
  article-title: Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections
  publication-title: Blood
– volume: 67
  start-page: 813
  issue: 6
  year: 2018
  end-page: 816
  article-title: A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology
  publication-title: Clin Infect Dis
– volume: 57
  start-page: 1731
  year: 2013
  end-page: 1741
  article-title: Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes
  publication-title: Clin Infect Dis
– year: 2023
  article-title: Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC). SARS‐CoV‐2‐reactive antibody waning, booster effect and breakthrough SARS‐CoV‐2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination
  publication-title: Bone Marrow Transplant
– volume: 15
  start-page: 474
  issue: 5
  year: 2013
  end-page: 486
  article-title: Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients
  publication-title: Transpl Infect Dis
– volume: 22
  start-page: 380
  issue: 4
  year: 2016
  article-title: Comparison of respiratory virus shedding by conventional and molecular testing methods in patients with haematological malignancy
  publication-title: Clin Microbiol Infect
– volume: 27
  start-page: 1826
  year: 2021
  end-page: 1837
  article-title: An open‐label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN‐β‐1a and hydroxychloroquine in hospitalized patients with COVID‐19
  publication-title: Clin Microbiol Infect
– volume: 19
  year: 2017
  article-title: A risk‐adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: a pilot study
  publication-title: Transpl Infect Dis
– volume: 55
  start-page: 431
  issue: 2
  year: 2020
  end-page: 440
  article-title: The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey
  publication-title: Bone Marrow Transplant
– volume: 14
  start-page: 555
  issue: 6
  year: 2012
  end-page: 563
  article-title: Fourth European Conference on Infections in Leukemia. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL‐4 (2011)
  publication-title: Transpl Infect Dis
– volume: 22
  issue: 6
  year: 2020
  article-title: Detection of community‐acquired respiratory viruses in allogeneic stem‐cell transplant recipients and controls‐a prospective cohort study
  publication-title: Transpl Infect Dis
– volume: 22
  start-page: 542
  year: 2016
  end-page: 548
  article-title: Outcomes of influenza infections in hematopoietic cell transplant recipients: application of an immunodeficiency scoring index
  publication-title: Biol Blood Marrow Transplant
– volume: 28
  start-page: 810
  issue: 12
  year: 2022
  end-page: 821
  article-title: Revised guidelines for Coronavirus disease 19 management in hematopoietic cell transplantation and cellular therapy recipients (August 2022)
  publication-title: Transplant Cell Ther
– volume: 36
  start-page: 1523
  year: 2003
  end-page: 1532
  article-title: Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double‐blind, randomized, placebo‐controlled trials
  publication-title: Clin Infect Dis
– volume: 19
  start-page: 1220
  issue: 8
  year: 2013
  end-page: 1226
  article-title: Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients
  publication-title: Biol Blood Marrow Transplant
– volume: 64
  start-page: 1532
  year: 2017
  end-page: 1539
  article-title: Clinical significance of human coronavirus in bronchoalveolar lavage samples from hematopoietic cell transplant recipients and patients with hematologic malignancies
  publication-title: Clin Infect Dis
– volume: 56
  start-page: 2212
  issue: 9
  year: 2021
  end-page: 2220
  article-title: Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS‐COV‐2 pandemic
  publication-title: Bone Marrow Transplant
– volume: 67
  issue: 1
  year: 2023
  article-title: A double‐blind, randomized, placebo‐controlled, phase II clinical study to evaluate the efficacy and safety of camostat mesylate (DWJ1248) in adult patients with mild to moderate COVID‐19
  publication-title: Antimicrob Agents Chemother
– volume: 35
  start-page: S73
  issue: 1
  year: 2005
  end-page: S76
  article-title: Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity
  publication-title: Bone Marrow Transplant
– volume: 60
  start-page: 85
  year: 2019
  end-page: 91
  article-title: Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)‐infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumab
  publication-title: Leuk Lymphoma
– volume: 225
  start-page: 1482
  year: 2022
  end-page: 1493
  article-title: Association of host factors with antibody response to seasonal influenza vaccination in allogeneic hematopoietic stem cell transplant patients
  publication-title: J Infect Dis
– volume: 81
  start-page: 1498
  issue: 8
  year: 2009
  end-page: 1507
  article-title: Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients
  publication-title: J Med Virol
– volume: 28
  start-page: 222
  year: 2022
  end-page: 238
  article-title: ESCMID COVID‐19 living guidelines: drug treatment and clinical management
  publication-title: Clin Microbiol Infect
– volume: 14
  start-page: 609
  year: 2014
  end-page: 618
  article-title: Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double‐blind, randomised, placebo‐controlled, phase 2b/3 trial
  publication-title: Lancet Infect Dis
– year: 2023
  article-title: Upper and/or lower respiratory tract infection caused by human metapneumovirus after allogeneic hematopoietic stem cell transplantation
  publication-title: J Infect Dis
– volume: 399
  start-page: 1941
  year: 2022
  end-page: 1953
  article-title: Remdesivir and three other drugs for hospitalised patients with COVID‐19: final results of the WHO Solidarity randomised trial and updated meta‐analyses
  publication-title: Lancet
– volume: 40
  start-page: 699
  year: 2007
  end-page: 700
  article-title: Human metapneumovirus infection in a hematopoietic transplant recipient
  publication-title: Bone Marrow Transplant
– volume: 223
  start-page: 1564
  issue: 9
  year: 2021
  end-page: 1575
  article-title: Seasonal human coronavirus respiratory tract infection in recipients of allogeneic hematopoietic stem cell transplantation
  publication-title: J Infect Dis
– volume: 30
  start-page: 82
  year: 2011
  end-page: 84
  article-title: Persistence of human bocavirus DNA in immunocompromised children
  publication-title: Pediatr Infect Dis J
– volume: 11
  start-page: 100
  year: 2009;
  end-page: 105
  article-title: Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation
  publication-title: Transpl Infect Dis
– volume: 85
  start-page: 278
  issue: 5
  year: 2006
  end-page: 287
  article-title: Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center
  publication-title: Medicine (Baltimore)
– volume: 57
  start-page: 1765
  issue: 12
  year: 2022
  end-page: 1773
  article-title: Exposure to antibiotics with anaerobic activity before respiratory viral infection is associated with respiratory disease progression after hematopoietic cell transplant
  publication-title: Bone Marrow Transplant
– volume: 68
  start-page: 1
  year: 2015
  end-page: 5
  article-title: The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients
  publication-title: J Clin Virol
– volume: 55
  start-page: 715
  year: 2017
  end-page: 723
  article-title: Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship
  publication-title: J Clin Microbiol
– volume: 44
  start-page: 749
  issue: 11
  year: 2009
  end-page: 756
  article-title: Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced‐intensity allogeneic hematopoietic SCT
  publication-title: Bone Marrow Transplant
– volume: 24
  start-page: 563
  issue: 3
  year: 2018
  end-page: 570
  article-title: Epidemiologic and clinical characteristics of coronavirus and bocavirus respiratory infections after allogeneic stem cell transplantation: a prospective single center study
  publication-title: Biol Blood Marrow Transplant
– volume: 1
  year: 2023
  article-title: Remdesivir for the treatment of COVID‐19
  publication-title: Cochrane Database Syst Rev
– year: 2020
– volume: 91
  start-page: e01659
  issue: 7
  year: 2017
  end-page: 16
  article-title: Human rhinovirus diversity and evolution: how strange the change from major to minor
  publication-title: J Virol
– volume: 20
  issue: 4
  year: 2018
  article-title: Community‐acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: risk factors and mortality from pulmonary virus‐bacterial mixed infections
  publication-title: Transpl Infect Dis
– volume: 24
  start-page: 333
  issue: 4
  year: 2011
  end-page: 343
  article-title: Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients
  publication-title: Curr Opin Infect Dis
– volume: 382
  start-page: 1787
  year: 2020
  end-page: 1799
  article-title: A trial of lopinavir‐ritonavir in adults hospitalized with severe Covid‐19
  publication-title: N Engl J Med
– volume: 35
  issue: 3
  year: 2022
  article-title: Digital PCR applications in the SARS‐CoV‐2/COVID‐19 era: a roadmap for future outbreaks
  publication-title: Clin Microbiol Rev
– volume: 206
  start-page: 1872
  issue: 12
  year: 2012
  end-page: 1877
  article-title: Influenza viral RNA detection in blood as a marker to predict disease severity in hematopoietic cell transplant recipients
  publication-title: J Infect Dis
– volume: 97
  start-page: 30
  issue: 1
  year: 2022
  end-page: 42
  article-title: Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC). SARS‐CoV‐2‐reactive antibody detection after SARS‐CoV‐2 vaccination in hematopoietic stem cell transplant recipients: prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group
  publication-title: Am J Hematol
– volume: 39
  start-page: 801
  year: 2001
  end-page: 803
  article-title: Molecular epidemiology of outbreak of respiratory syncytial virus within bone marrow transplantation unit
  publication-title: J Clin Microbiol
– volume: 216
  start-page: 203
  year: 2017
  end-page: 209
  article-title: Prolonged shedding of human coronavirus in hematopoietic cell transplant recipients: risk factors and viral genome evolution
  publication-title: J Infect Dis
– volume: 379
  start-page: 100
  issue: 1
  year: 2016
  end-page: 106
  article-title: Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: a systematic review
  publication-title: Cancer Lett
– volume: 57
  start-page: 1731
  issue: 12
  year: 2013
  end-page: 1741
  article-title: Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes
  publication-title: Clin Infect Dis
– volume: 115
  start-page: 1331
  issue: 7
  year: 2010
  end-page: 1342
  article-title: How I treat influenza in patients with hematologic malignancies
  publication-title: Blood
– volume: 56
  start-page: 3032
  year: 2021
  end-page: 3041
  article-title: Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients
  publication-title: Bone Marrow Transplant
– volume: 396
  start-page: 1345
  issue: 10259
  year: 2020
  end-page: 1352
  article-title: Lopinavir‐ritonavir in patients admitted to hospital with COVID‐19 (RECOVERY): a randomised, controlled, open‐label, platform trial
  publication-title: Lancet
– volume: 15
  start-page: 54
  issue: 1
  year: 2022
  article-title: Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC). SARS‐CoV‐2 vaccine response and rate of breakthrough infection in patients with hematological disorders
  publication-title: J Hematol Oncol
– volume: 9
  start-page: 1407
  year: 2021
  end-page: 1418
  article-title: Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID‐19 (COV‐BARRIER): a randomised, double‐blind, parallel‐group, placebo‐controlled phase 3 trial
  publication-title: Lancet Respir Med
– volume: S2213‐2600
  start-page: 00412
  issue: 22
  year: 2022
  end-page: X
  article-title: Favipiravir in patients hospitalised with COVID‐19 (PIONEER trial): a multicentre, open‐label, phase 3, randomised controlled trial of early intervention versus standard care
  publication-title: Lancet Respir Med
– volume: 17
  start-page: 566
  issue: 4
  year: 2011
  end-page: 573
  article-title: Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers’ experiences
  publication-title: Biol Blood Marrow Transplant
– volume: 195
  start-page: 194
  issue: 2
  year: 2021
  end-page: 197
  article-title: Reduction in incidence of non‐COVID‐19 respiratory virus infection amongst haematology inpatients following UK social distancing measures
  publication-title: Br J Haematol
– volume: 103
  start-page: 1611
  year: 2004
  end-page: 1617
  article-title: The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management
  publication-title: Blood
– volume: 24
  start-page: 4847
  issue: 5
  year: 2023
  article-title: Comparison of SARS‐CoV‐2 detection in nasopharyngeal swab and saliva samples from patients infected with Omicron variant
  publication-title: Int J Mol Sci
– volume: 5
  year: 2018
  article-title: Community‐acquired respiratory paramyxovirus infection after allogeneic hematopoietic cell transplantation: a single‐center experience
  publication-title: Open Forum Infect Dis
– volume: 46
  start-page: 402
  issue: 3
  year: 2008
  end-page: 412
  article-title: Respiratory syncytial virus infection in patients with hematological diseases: single‐center study and review of the literature
  publication-title: Clin Infect Dis
– volume: 110
  start-page: 1681
  year: 2007
  end-page: 1688
  article-title: Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection
  publication-title: Blood
– volume: 25
  start-page: 163
  issue: 1
  year: 2019
  end-page: 171
  article-title: Risk factors for parainfluenza virus lower respiratory tract disease after hematopoietic cell transplantation
  publication-title: Biol Blood Marrow Transplant
– volume: 90
  start-page: 413
  year: 2013
  end-page: 419
  article-title: Adjuvanted influenza A (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy‐treated patients
  publication-title: Eur J Haematol
– volume: 39
  start-page: 1300
  issue: 9
  year: 2004
  end-page: 1306
  article-title: Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy
  publication-title: Clin Infect Dis
– volume: 2
  start-page: 203
  year: 2012
  end-page: 218
  article-title: Management of respiratory viral infections in hematopoietic cell transplant recipients
  publication-title: Am J Blood Res
– volume: 48
  start-page: 1548
  year: 2013
  end-page: 1553
  article-title: Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit
  publication-title: Bone Marrow Transplant
– volume: 71
  start-page: 109
  issue: 2
  year: 2018
  end-page: 115
  article-title: Human parainfluenza virus type 3 infections in patients with hematopoietic stem cell transplants: the mode of nosocomial infections and prognosis
  publication-title: Jpn J Infect Dis
– volume: 119
  start-page: 2738
  issue: 12
  year: 2012
  end-page: 2745
  article-title: The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation
  publication-title: Blood
– volume: 388
  start-page: 406
  year: 2023
  end-page: 417
  article-title: VV116 versus nirmatrelvir‐ritonavir for oral treatment of Covid‐19
  publication-title: N Engl J Med
– volume: 23
  issue: 4
  year: 2021
  article-title: Adoptive transfer of ex vivo expanded SARS‐CoV‐2‐specific cytotoxic lymphocytes: a viable strategy for COVID‐19 immunosuppressed patients?
  publication-title: Transpl Infect Dis
– volume: 105
  start-page: 235
  issue: 1
  year: 2020
  end-page: 243
  article-title: Rapid generation of multivirus‐specific T lymphocytes for the prevention and treatment of respiratory viral infections
  publication-title: Haematologica
– volume: 26
  start-page: 323
  issue: 3
  year: 2022
  end-page: 331
  article-title: Clinical Performance of the cobas Liat SARS‐CoV‐2 & influenza A/B assay in nasal samples
  publication-title: Mol Diagn Ther
– volume: 384
  start-page: 905
  year: 2021
  end-page: 914
  article-title: A neutralizing monoclonal antibody for hospitalized patients with Covid‐19
  publication-title: N Engl J Med
– volume: 112
  start-page: 1191
  year: 2022
  end-page: 1200
  article-title: Recommendations for the management of drug‐drug interactions between the COVID‐19 antiviral nirmatrelvir/ritonavir (paxlovid) and comedications
  publication-title: Clin Pharmacol Ther
– volume: 22
  year: 2020
  article-title: Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes
  publication-title: Transpl Infect Dis
– volume: 13
  start-page: 1665
  year: 2021
  article-title: Antiviral activity of umifenovir in vitro against a broad spectrum of coronaviruses, including the novel SARS‐CoV‐2 virus
  publication-title: Viruses
– volume: 57
  start-page: 1807
  issue: 8
  year: 2016
  end-page: 1813
  article-title: Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessment
  publication-title: Leuk Lymphoma
– volume: 6
  start-page: 5307
  issue: 18
  year: 2022
  end-page: 5316
  article-title: Respiratory viruses in hematopoietic cell transplant candidates: impact of preexisting lower tract disease on outcomes
  publication-title: Blood Adv
– volume: 384
  start-page: 795
  year: 2021
  end-page: 807
  article-title: Baricitinib plus remdesivir for hospitalized adults with Covid‐19
  publication-title: N Engl J Med
– volume: 20
  start-page: 1204
  year: 2020
  end-page: 1214
  article-title: Early treatment with baloxavir marboxil in high‐risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE‐2): a randomised, placebo‐controlled, phase 3 trial
  publication-title: Lancet Infect Dis
– volume: 386
  start-page: 509
  year: 2022
  end-page: 520
  article-title: Molnupiravir for oral treatment of Covid‐19 in nonhospitalized patients
  publication-title: N Engl J Med
– volume: 75
  start-page: 1883
  year: 2022
  end-page: 1892
  article-title: Favipiravir for treatment of outpatients with asymptomatic or uncomplicated Coronavirus disease 2019: a double‐blind, randomized, placebo‐controlled, phase 2 trial
  publication-title: Clin Infect Dis
– volume: 192
  start-page: 1061
  year: 2005
  end-page: 1065
  article-title: A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections
  publication-title: J Infect Dis
– volume: 55
  start-page: 2261
  issue: 12
  year: 2020
  end-page: 2269
  article-title: Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation
  publication-title: Bone Marrow Transplant
– volume: 102
  start-page: 1120
  year: 2017
  end-page: 1130
  article-title: Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality
  publication-title: Haematologica
– volume: 16
  start-page: 192
  issue: 2
  year: 2010
  end-page: 198
  article-title: Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients
  publication-title: Biol Blood Marrow Transplant
– volume: 17
  start-page: 979
  issue: 7
  year: 2011
  end-page: 986
  article-title: Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus
  publication-title: Biol Blood Marrow Transplant
– volume: 5
  start-page: 135
  year: 2017
  end-page: 146
  article-title: Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double‐blind, double‐dummy, phase 3 trial
  publication-title: Lancet Respir Med
– volume: 19
  start-page: 589
  year: 2013
  end-page: 596
  article-title: Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement
  publication-title: Biol Blood Marrow Transplant
– volume: 10
  issue: 3
  year: 2022
  article-title: Detectable duration of viable SARS‐CoV‐2, total and subgenomic SARS‐CoV‐2 RNA in noncritically Ill COVID‐19 patients: a prospective cohort study
  publication-title: Microbiol Spectr
– volume: 47
  start-page: 867
  year: 2021
  end-page: 886
  article-title: Lopinavir‐ritonavir and hydroxychloroquine for critically ill patients with COVID‐19: REMAP‐CAP randomized controlled trial
  publication-title: Intensive Care Med
– volume: 104
  start-page: 1322
  issue: 7
  year: 2019
  end-page: 1331
  article-title: Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies
  publication-title: Haematologica
– volume: 68
  start-page: 1894
  issue: 11
  year: 2019
  end-page: 1903
  article-title: Clinical effectiveness of influenza vaccination after allogeneic hematopoietic stem cell transplantation: a cross‐sectional, prospective, observational study
  publication-title: Clin Infect Dis
– volume: 26
  start-page: 862
  year: 2007
  end-page: 864
  article-title: Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin
  publication-title: J Heart Lung Transplant
– volume: 19
  start-page: e200
  issue: 6
  year: 2019
  end-page: e212
  article-title: European Conference on Infections in Leukaemia group. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)
  publication-title: Lancet Infect Dis
– volume: 383
  start-page: 2291
  year: 2020
  end-page: 2293
  article-title: Persistence and evolution of SARS‐CoV‐2 in an immunocompromised host
  publication-title: N Engl J Med
– volume: 51
  start-page: 155
  year: 2013
  end-page: 162
  article-title: Molecular characterization of a respiratory syncytial virus (RSV) outbreak in a hematology unit, Heidelberg, Germany
  publication-title: J Clin Microbiol
– volume: 47
  start-page: 132
  issue: 3
  year: 2021
  end-page: 138
  article-title: Seasonality of coronaviruses and other respiratory viruses in Canada: implications for COVID‐19
  publication-title: Can Commun Dis Rep
– volume: 32
  issue: 5
  year: 2022
  article-title: Detection of respiratory viruses directly from clinical samples using next‐generation sequencing: a literature review of recent advances and potential for routine clinical use
  publication-title: Rev Med Virol
– volume: 20
  start-page: 342
  issue: 1
  year: 2022
  article-title: A multicenter, double‐blind, randomized, parallel‐group, placebo‐controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID‐19 (CANDLE study)
  publication-title: BMC Med
– volume: 53
  start-page: 3738
  issue: 12
  year: 2015
  end-page: 3749
  article-title: Diagnostic accuracy of rapid antigen detection tests for respiratory syncytial virus infection: systematic review and meta‐analysis
  publication-title: J Clin Microbiol
– volume: 21
  issue: 5
  year: 2019
  article-title: Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients
  publication-title: Transpl Infect Dis
– volume: 18
  start-page: 148
  issue: 3
  year: 2023
  end-page: 156
  article-title: The origins of new SARS‐COV‐2 variants in immuncompromised individuals
  publication-title: Curr Opin HIV AIDS
– volume: 188
  start-page: 560
  issue: 4
  year: 2020
  end-page: 569
  article-title: Delaying haematopoietic stem cell transplantation in children with viral respiratory infections reduces transplant‐related mortality
  publication-title: Br J Haematol
– volume: 36
  start-page: 1
  issue: 1
  year: 2003
  end-page: 8
  article-title: Respiratory virus infections in adults with hematologic malignancies: a prospective study
  publication-title: Clin Infect Dis
– volume: 11
  year: 2021
  article-title: Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models
  publication-title: Sci Rep
– volume: 12
  year: 2021
  article-title: Favipiravir versus arbidol for clinical recovery rate in moderate and severe adult COVID‐19 patients: a prospective, multicenter, open‐label, randomized controlled clinical trial
  publication-title: Front Pharmacol
– volume: 219
  start-page: 1026
  year: 2019
  end-page: 1034
  article-title: Phase 2b Study of Pimodivir (JNJ‐63623872) as monotherapy or in combination with oseltamivir for treatment of acute uncomplicated seasonal influenza A: TOPAZ trial
  publication-title: J Infect Dis
– volume: 16
  start-page: 165
  issue: 1
  year: 2014
  end-page: 169
  article-title: Prolonged respiratory viral shedding in transplant patients
  publication-title: Transpl Infect Dis
– volume: 216
  start-page: 153
  issue: 2
  year: 2017
  end-page: 161
  article-title: Characterizing the cellular immune response to parainfluenza virus 3
  publication-title: J Infect Dis
– volume: 16
  start-page: 132
  year: 2016
  end-page: 142
  article-title: Human influenza viruses and CD8(+) T cell responses
  publication-title: Curr Opin Virol
– volume: 28
  start-page: 51
  year: 2001
  end-page: 57
  article-title: Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study
  publication-title: Bone Marrow Transplant
– volume: 15
  start-page: 474
  year: 2013
  end-page: 486
  article-title: Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients
  publication-title: Transpl Infect Dis
– volume: 15
  start-page: 219
  issue: 3
  year: 2013
  end-page: 232
  article-title: European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL‐4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN
  publication-title: Transpl Infect Dis
– volume: 145
  start-page: 667
  year: 2009
  end-page: 669
  article-title: Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin
  publication-title: Br J Haematol
– volume: 38
  start-page: 29
  issue: 1
  year: 2017
  end-page: 36
  article-title: Respiratory syncytial virus infection: an illness for all ages
  publication-title: Clin Chest Med
– year: 2022
  article-title: Breakthrough COVID‐19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey
  publication-title: Blood
– volume: 168
  start-page: 208
  year: 2003
  end-page: 214
  article-title: Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation
  publication-title: Am J Respir Crit Care Med
– volume: 88
  start-page: 11760
  issue: 20
  year: 2014
  end-page: 11773
  article-title: Immunodominant CD4+ T‐cell responses to influenza A virus in healthy individuals focus on matrix 1 and nucleoprotein
  publication-title: J Virol
– volume: 73
  start-page: 2073
  issue: 11
  year: 2021
  end-page: 2082
  article-title: Vaccinated and convalescent donor‐derived severe acute respiratory syndrome Coronavirus 2‐specific T cells as adoptive immunotherapy for high‐risk Coronavirus disease 2019 patients
  publication-title: Clin Infect Dis
– volume: 19
  start-page: 387
  year: 2013
  end-page: 392
  article-title: Adenovirus viremia and disease: comparison of T cell‐depleted and conventional hematopoietic stem cell transplantation recipients from a single institution
  publication-title: Biol Blood Marrow Transplant
– volume: 150‐151
  year: 2022
  article-title: Correlation of initial upper respiratory tract viral burden with progression to lower tract disease in adult allogeneic hematopoietic cell transplant recipients
  publication-title: J Clin Virol
– volume: 24
  start-page: 2160
  issue: 10
  year: 2018
  end-page: 2163
  article-title: Initial high viral load is associated with prolonged shedding of human rhinovirus in allogeneic hematopoietic cell transplant recipients
  publication-title: Biol Blood Marrow Transplant
– volume: 16
  start-page: 756
  issue: 4
  year: 2022
  end-page: 766
  article-title: Prevalence and seasonality of viral respiratory infections in a temperate climate region: a 24‐year study (1997‐2020)
  publication-title: Influenza Other Respir Viruses
– volume: 25
  start-page: 800
  year: 2019
  end-page: 809
  article-title: Pulmonary Impairment after respiratory viral infections is associated with high mortality in allogeneic hematopoietic cell transplant recipients
  publication-title: Biol Blood Marrow Transplant
– volume: 15
  start-page: 27
  year: 2022
  article-title: Determinants of SARS‐CoV‐2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
  publication-title: J Hematol Oncol
– volume: 25
  start-page: 1011
  issue: 5
  year: 2019
  end-page: 1021
  article-title: Human rhinovirus infections in hematopoietic cell transplant recipients: risk score for progression to lower respiratory tract infection
  publication-title: Biol Blood Marrow Transplant
– volume: 16
  start-page: 782
  issue: 6
  year: 2010
  end-page: 791
  article-title: Strong association between respiratory viral infection early after hematopoietic stem cell transplantation and the development of life‐threatening acute and chronic alloimmune lung syndromes
  publication-title: Biol Blood Marrow Transplant
– volume: 134
  start-page: 64
  issue: 1
  year: 2006
  end-page: 76
  article-title: Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation
  publication-title: Br J Haematol
– volume: 9
  start-page: 678
  year: 2018
  article-title: The CD8 T cell response to respiratory virus infections
  publication-title: Front Immunol
– volume: 68
  start-page: 895
  year: 2019
  end-page: 902
  article-title: Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa
  publication-title: Clin Infect Dis
– volume: 27
  start-page: 441
  year: 2014
  end-page: 462
  article-title: Adenovirus infections in immunocompetent and immunocompromised patients
  publication-title: Clin Microbiol Rev
– volume: 98
  start-page: 573
  year: 2001
  end-page: 578
  article-title: Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome
  publication-title: Blood
– volume: 7
  start-page: 1161
  year: 2022
  end-page: 1179
  article-title: SARS‐CoV‐2 Omicron is an immune escape variant with an altered cell entry pathway
  publication-title: Nat Microbiol
– volume: 76
  start-page: iii58
  year: 2021
  end-page: iii66
  article-title: A discussion of syndromic molecular testing for clinical care
  publication-title: J Antimicrob Chemother
– volume: 226
  start-page: 1790
  year: 2022
  end-page: 1799
  article-title: Favipiravir treatment of uncomplicated influenza in adults: results of two phase 3, randomized, double‐blind, placebo‐controlled trials
  publication-title: J Infect Dis
– volume: 76
  start-page: iii4
  year: 2021
  end-page: iii11
  article-title: Syndromic diagnostic testing: a new way to approach patient care in the treatment of infectious diseases
  publication-title: J Antimicrob Chemother
– volume: 193
  start-page: 1619
  issue: 12
  year: 2006
  end-page: 1625
  article-title: Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses
  publication-title: J Infect Dis
– volume: 73
  start-page: e4392
  issue: 11
  year: 2021
  end-page: e4399
  article-title: Role of human bocavirus respiratory tract infection in hematopoietic cell transplant recipients
  publication-title: Clin Infect Dis
– volume: 98
  start-page: 573
  issue: 3
  year: 2001
  end-page: 578
  article-title: Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome
  publication-title: Blood
– volume: 174
  start-page: 1392
  issue: 12
  year: 2006
  end-page: 1399
  article-title: Chronic rhinoviral infection in lung transplant recipients
  publication-title: Am J Respir Crit Care Med
– volume: 68
  start-page: 1872
  year: 2013
  end-page: 1880
  article-title: Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections
  publication-title: J Antimicrob Chemother
– volume: 221
  start-page: 1688
  year: 2020
  end-page: 1698
  article-title: Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically Ill patients with influenza virus infection
  publication-title: J Infect Dis
– volume: 28
  start-page: 1203
  year: 2022
  end-page: 1210
  article-title: Remdesivir for the treatment of COVID‐19: a systematic review and meta‐analysis
  publication-title: Clin Microbiol Infect
– volume: 33
  start-page: 425
  issue: 4
  year: 2004
  end-page: 430
  article-title: Enterovirus infections following T‐cell depleted allogeneic transplants in adults
  publication-title: Bone Marrow Transplant
– volume: 17
  issue: 7
  year: 2022
  article-title: Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: analysis of clinical characteristics, nosocomial transmission and viral shedding
  publication-title: PLoS One
– volume: 59
  start-page: S344
  issue: 5
  year: 2014
  end-page: S351
  article-title: Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies
  publication-title: Clin Infect Dis
– volume: 10
  start-page: 1856
  issue: 9
  year: 2022
  article-title: Respiratory tract infections and laboratory diagnostic methods: a review with a focus on syndromic panel‐based assays
  publication-title: Microorganisms
– volume: 18
  start-page: 1580
  year: 2012
  end-page: 1588
  article-title: Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time
  publication-title: Biol Blood Marrow Transplant
– volume: 100
  start-page: 1619
  year: 2002
  end-page: 1627
  article-title: Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery
  publication-title: Blood
– volume: 138
  start-page: 301
  issue: 1
  year: 2021
  article-title: Multicenter, open‐label, phase 3 study of tabelecleucel for solid organ or allogeneic hematopoietic cell transplant recipients with Epstein‐Barr virus‐driven post transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE)
  publication-title: Blood
– volume: 140
  start-page: 5096
  year: 2022
  end-page: 5097
  article-title: The trend of respiratory virus infection in allogeneic bone marrow transplant recipients during the COVID pandemic
  publication-title: Blood
– volume: 50
  start-page: 1061
  year: 2012
  end-page: 1063
  article-title: Severity of human rhinovirus infection in immunocompromised adults is similar to that of 2009 H1N1 influenza
  publication-title: J Clin Microbiol
– volume: 11
  start-page: 781
  issue: 10
  year: 2005
  end-page: 96
  article-title: Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies
  publication-title: Biol Blood Marrow Transplant
– volume: 14
  year: 2023
  article-title: Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID‐19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry
  publication-title: Front Immunol
– volume: 58
  start-page: 1357
  year: 2014
  end-page: 1368
  article-title: Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome
  publication-title: Clin Infect Dis
– volume: 39
  start-page: 673
  year: 2004
  end-page: 680
  article-title: Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation
  publication-title: Clin Infect Dis
– ident: e_1_2_16_126_1
  doi: 10.1016/S0140-6736(22)02597-1
– ident: e_1_2_16_20_1
  doi: 10.1128/JCM.00789-11
– ident: e_1_2_16_64_1
  doi: 10.1097/01.md.0000232560.22098.4e
– ident: e_1_2_16_153_1
  doi: 10.1093/jac/dkt111
– ident: e_1_2_16_48_1
  doi: 10.1016/j.bbmt.2009.06.019
– ident: e_1_2_16_33_1
  doi: 10.1016/j.cmi.2020.11.004
– ident: e_1_2_16_218_1
  doi: 10.1016/j.ccm.2016.11.010
– ident: e_1_2_16_97_1
  doi: 10.1371/journal.pone.0271756
– ident: e_1_2_16_75_1
  doi: 10.1016/j.bbmt.2012.12.019
– ident: e_1_2_16_46_1
  doi: 10.1086/598627
– volume: 195
  start-page: E220
  year: 2023
  ident: e_1_2_16_131_1
  article-title: Population‐based evaluation of the effectiveness of nirmatrelvir‐ritonavir for reducing hospital admissions and mortality from COVID‐19
  publication-title: Randomized Controlled Trial
– ident: e_1_2_16_36_1
  doi: 10.1093/cid/ciy584
– ident: e_1_2_16_58_1
  doi: 10.1016/j.bbmt.2018.08.021
– ident: e_1_2_16_116_1
  doi: 10.1093/infdis/jiz656
– ident: e_1_2_16_61_1
  doi: 10.1093/cid/cit639
– ident: e_1_2_16_171_1
  doi: 10.1016/j.canlet.2016.05.035
– ident: e_1_2_16_9_1
  doi: 10.1097/COH.0000000000000794
– ident: e_1_2_16_127_1
  doi: 10.1128/AAC.00766-18
– ident: e_1_2_16_180_1
  doi: 10.1002/ajh.26385
– ident: e_1_2_16_194_1
  doi: 10.1182/blood-2002-02-0377
– ident: e_1_2_16_39_1
  doi: 10.1128/jcm.01785-21
– ident: e_1_2_16_91_1
  doi: 10.1164/rccm.200212‐1468OC
– ident: e_1_2_16_117_1
  doi: 10.1016/S2213‐2600(22)00412‐X
– ident: e_1_2_16_121_1
  doi: 10.1056/NEJMoa2001282
– ident: e_1_2_16_144_1
  doi: 10.1111/tid.13276
– ident: e_1_2_16_152_1
  doi: 10.3324/haematol.2018.215152
– ident: e_1_2_16_38_1
  doi: 10.3390/ijms24054847
– ident: e_1_2_16_167_1
  doi: 10.1016/j.canlet.2015.11.014
– ident: e_1_2_16_85_1
  doi: 10.1111/tid.13301
– ident: e_1_2_16_139_1
  doi: 10.1016/S0140-6736(22)00519-0
– ident: e_1_2_16_57_1
  doi: 10.1016/j.bbmt.2013.05.005
– ident: e_1_2_16_56_1
  doi: 10.1093/cid/ciu623
– ident: e_1_2_16_128_1
  doi: 10.1056/NEJMoa2208822
– ident: e_1_2_16_25_1
  doi: 10.1128/JCM.00367-18
– ident: e_1_2_16_80_1
  doi: 10.7883/yoken.JJID.2017.424
– ident: e_1_2_16_136_1
  doi: 10.1016/j.bbmt.2016.07.005
– ident: e_1_2_16_93_1
  doi: 10.1182/blood‐2010‐11‐319186
– ident: e_1_2_16_120_1
  doi: 10.1038/s41598-021-02972-y
– ident: e_1_2_16_148_1
  doi: 10.1016/S2213-2600(16)30435-0
– ident: e_1_2_16_211_1
  doi: 10.18632/oncotarget.10182
– ident: e_1_2_16_70_1
  doi: 10.1016/j.bbmt.2015.11.015
– ident: e_1_2_16_108_1
  doi: 10.1016/j.cmi.2021.11.007
– ident: e_1_2_16_182_1
  doi: 10.1186/s13045-022-01250-2
– ident: e_1_2_16_15_1
  doi: 10.1086/344899
– ident: e_1_2_16_104_1
  doi: 10.1164/rccm.200604-489OC
– ident: e_1_2_16_92_1
  doi: 10.1093/cid/ciy760
– ident: e_1_2_16_190_1
  doi: 10.1128/CMR.00116-13
– ident: e_1_2_16_130_1
  doi: 10.1002/cpt.2646
– ident: e_1_2_16_10_1
  doi: 10.1111/tid.13415
– ident: e_1_2_16_132_1
  doi: 10.1016/S1473-3099(14)70717-0
– ident: e_1_2_16_205_1
  doi: 10.1016/j.cmi.2015.12.012
– ident: e_1_2_16_231_1
  doi: 10.3324/haematol.2014.116772
– ident: e_1_2_16_50_1
  doi: 10.1111/bjh.16216
– ident: e_1_2_16_16_1
  doi: 10.1016/j.bbmt.2005.07.007
– ident: e_1_2_16_122_1
  doi: 10.1016/S0140-6736(20)32013-4
– ident: e_1_2_16_160_1
  doi: 10.1038/bmt.2008.264
– ident: e_1_2_16_208_1
  doi: 10.1016/j.bbmt.2019.12.724
– ident: e_1_2_16_178_1
  doi: 10.1038/s41375-021-01302-5
– ident: e_1_2_16_32_1
  doi: 10.1093/cid/ciaa1764
– ident: e_1_2_16_84_1
  doi: 10.1038/s41375‐021‐01302‐5
– ident: e_1_2_16_103_1
  doi: 10.1002/jmv.21548
– ident: e_1_2_16_12_1
  doi: 10.1093/infdis/jiaa553
– ident: e_1_2_16_215_1
  doi: 10.1182/blood‐2021‐147274
– ident: e_1_2_16_162_1
  doi: 10.1016/j.bbmt.2010.07.018
– ident: e_1_2_16_8_1
  doi: 10.1056/NEJMsb2104756
– ident: e_1_2_16_74_1
  doi: 10.1016/j.bbmt.2012.04.012
– ident: e_1_2_16_234_1
  doi: 10.1038/bmt.2017.24
– ident: e_1_2_16_60_1
  doi: 10.1093/cid/ciw284
– ident: e_1_2_16_141_1
  doi: 10.1056/NEJMoa2031994
– ident: e_1_2_16_23_1
  doi: 10.3389/fmicb.2018.02478
– ident: e_1_2_16_99_1
  doi: 10.1182/bloodadvances.2020003865
– ident: e_1_2_16_201_1
  doi: 10.1371/journal.pone.0148258
– ident: e_1_2_16_184_1
  doi: 10.1038/s41408-022-00778-3
– ident: e_1_2_16_59_1
  doi: 10.1038/sj.bmt.1703139
– ident: e_1_2_16_147_1
  doi: 10.1002/iid3.502
– ident: e_1_2_16_30_1
  doi: 10.1093/jac/dkab243
– ident: e_1_2_16_135_1
  doi: 10.1080/10428194.2018.1468896
– ident: e_1_2_16_52_1
  doi: 10.3390/v14020267
– ident: e_1_2_16_196_1
  doi: 10.1093/cid/ciaa1149
– ident: e_1_2_16_137_1
  doi: 10.1093/infdis/jiy547
– ident: e_1_2_16_114_1
  doi: 10.1016/j.cmi.2019.10.012
– ident: e_1_2_16_49_1
  doi: 10.1086/422994
– ident: e_1_2_16_202_1
  doi: 10.1128/JCM.02151‐12
– ident: e_1_2_16_224_1
  doi: 10.3324/haematol.2022.281946
– ident: e_1_2_16_73_1
  doi: 10.1038/bmt.2013.94
– ident: e_1_2_16_24_1
  doi: 10.3390/microorganisms10091856
– ident: e_1_2_16_81_1
  doi: 10.1016/j.bbmt.2009.09.014
– ident: e_1_2_16_133_1
  doi: 10.1183/13993003.03725-2020
– ident: e_1_2_16_222_1
  doi: 10.1093/cid/ciab371
– ident: e_1_2_16_204_1
  doi: 10.1007/s00705‐013‐1610‐1
– ident: e_1_2_16_28_1
  doi: 10.1128/JCM.02264-16
– ident: e_1_2_16_3_1
  doi: 10.1186/s40164‐020‐00177‐z
– ident: e_1_2_16_193_1
  doi: 10.1038/sj.bmt.1703083
– ident: e_1_2_16_54_1
  doi: 10.1016/j.jtct.2022.09.002
– ident: e_1_2_16_118_1
  doi: 10.1093/cid/ciac312
– ident: e_1_2_16_55_1
  doi: 10.1093/cid/cit639
– ident: e_1_2_16_232_1
  doi: 10.1093/infdis/jiab391
– ident: e_1_2_16_170_1
  doi: 10.1111/irv.12972
– ident: e_1_2_16_216_1
  doi: 10.1016/j.coviro.2016.01.016
– ident: e_1_2_16_125_1
  doi: 10.1056/NEJMoa2116044
– ident: e_1_2_16_212_1
  doi: 10.1111/tid.13158
– ident: e_1_2_16_210_1
  doi: 10.1182/blood.V98.3.573
– ident: e_1_2_16_119_1
  doi: 10.3389/fphar.2021.683296
– ident: e_1_2_16_229_1
  doi: 10.1038/s41564-022-01143-7
– ident: e_1_2_16_5_1
  doi: 10.1111/bjh.17651
– ident: e_1_2_16_168_1
  doi: 10.1086/432732
– ident: e_1_2_16_143_1
  doi: 10.1016/S1473-3099(21)00485-0
– ident: e_1_2_16_233_1
  doi: 10.1038/s41409-019-0728-5
– ident: e_1_2_16_198_1
  doi: 10.1097/INF.0b013e3181f12fcf
– ident: e_1_2_16_154_1
  doi: 10.1086/525263
– ident: e_1_2_16_220_1
  doi: 10.1093/infdis/jix358
– ident: e_1_2_16_66_1
  doi: 10.1038/s41409‐019‐0698‐7
– ident: e_1_2_16_18_1
  doi: 10.1016/j.bbmt.2017.11.001
– ident: e_1_2_16_2_1
  doi: 10.1016/j.idc.2019.02.004
– ident: e_1_2_16_174_1
  doi: 10.7326/0003-4819-144-5-200603070-00010
– ident: e_1_2_16_13_1
  doi: 10.1093/infdis/jiad268
– ident: e_1_2_16_191_1
  doi: 10.1016/j.bbmt.2012.10.014
– ident: e_1_2_16_47_1
  doi: 10.1128/JCM.06579-11
– ident: e_1_2_16_207_1
  doi: 10.1038/bmt.2009.78
– ident: e_1_2_16_14_1
  doi: 10.1038/s41408‐022‐00778‐3
– ident: e_1_2_16_226_1
  doi: 10.1056/NEJMoa2106062
– ident: e_1_2_16_110_1
  doi: 10.1056/NEJMoa2033130
– ident: e_1_2_16_177_1
  doi: 10.1016/j.healun.2007.05.020
– ident: e_1_2_16_44_1
  doi: 10.1016/j.jinf.2019.12.022
– ident: e_1_2_16_165_1
  doi: 10.1016/S1473-3099(09)70175-6
– ident: e_1_2_16_197_1
  doi: 10.3201/eid1309.070318
– ident: e_1_2_16_158_1
  doi: 10.1182/blood-2009-11-255455
– volume: 1
  year: 2023
  ident: e_1_2_16_140_1
  article-title: Remdesivir for the treatment of COVID‐19
  publication-title: Cochrane Database Syst Rev
– volume: 2
  start-page: 203
  year: 2012
  ident: e_1_2_16_150_1
  article-title: Management of respiratory viral infections in hematopoietic cell transplant recipients
  publication-title: Am J Blood Res
– ident: e_1_2_16_76_1
  doi: 10.1111/tid.12111
– ident: e_1_2_16_79_1
  doi: 10.3324/haematol.2016.153767
– ident: e_1_2_16_42_1
  doi: 10.1093/cid/cis844
– ident: e_1_2_16_88_1
  doi: 10.1111/tid.12926
– ident: e_1_2_16_35_1
  doi: 10.1038/s41598-021-97700-x
– ident: e_1_2_16_195_1
  doi: 10.1111/j.1365-2141.2006.06108.x
– ident: e_1_2_16_138_1
  doi: 10.1086/375069
– ident: e_1_2_16_214_1
  doi: 10.1182/blood.2022016202
– ident: e_1_2_16_109_1
  doi: 10.1016/j.cmi.2022.04.018
– ident: e_1_2_16_145_1
  doi: 10.1111/tid.12729
– ident: e_1_2_16_90_1
  doi: 10.1016/j.bbmt.2009.12.534
– ident: e_1_2_16_100_1
  doi: 10.1038/s41409‐023‐01946‐0
– ident: e_1_2_16_105_1
  doi: 10.1016/j.bbmt.2018.07.006
– ident: e_1_2_16_134_1
  doi: 10.1007/s40121-019-00271-8
– ident: e_1_2_16_21_1
  doi: 10.1128/JCM.01816-15
– ident: e_1_2_16_176_1
  doi: 10.1038/sj.bmt.1705781
– ident: e_1_2_16_17_1
  doi: 10.1182/blood-2009-09-244152
– ident: e_1_2_16_142_1
  doi: 10.1016/S2213-2600(21)00331-3
– ident: e_1_2_16_78_1
  doi: 10.1016/j.bbmt.2018.12.005
– ident: e_1_2_16_101_1
  doi: 10.3389/fimmu.2023.1125824
– ident: e_1_2_16_155_1
– ident: e_1_2_16_219_1
  doi: 10.1128/CMR.00010‐16
– ident: e_1_2_16_228_1
  doi: 10.1128/JVI.01659-16
– ident: e_1_2_16_113_1
  doi: 10.1186/s12916-022-02518-7
– ident: e_1_2_16_68_1
  doi: 10.1016/j.bbmt.2018.05.016
– ident: e_1_2_16_199_1
  doi: 10.1111/tid.12167
– ident: e_1_2_16_203_1
  doi: 10.1128/JCM.39.2.801-803.2001
– ident: e_1_2_16_65_1
  doi: 10.1038/s41409‐020‐0943‐0
– ident: e_1_2_16_6_1
  doi: 10.1038/s41409‐021‐01319‐5
– ident: e_1_2_16_186_1
  doi: 10.1016/S0140‐6736(21)01594‐4
– ident: e_1_2_16_72_1
  doi: 10.1093/infdis/jix264
– ident: e_1_2_16_225_1
  doi: 10.3324/haematol.2018.206896
– volume: 35
  start-page: S73
  issue: 1
  year: 2005
  ident: e_1_2_16_192_1
  article-title: Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity
  publication-title: Bone Marrow Transplant
– ident: e_1_2_16_87_1
  doi: 10.1038/s41409‐021‐01462‐z
– ident: e_1_2_16_187_1
  doi: 10.1016/j.jcv.2015.04.012
– ident: e_1_2_16_22_1
  doi: 10.1128/JCM.01816-15
– ident: e_1_2_16_53_1
  doi: 10.1093/cid/civ272
– ident: e_1_2_16_43_1
  doi: 10.1093/cid/ciu134
– ident: e_1_2_16_89_1
  doi: 10.1086/504268
– ident: e_1_2_16_7_1
  doi: 10.1056/NEJMc2031364
– ident: e_1_2_16_19_1
  doi: 10.14745/ccdr.v47i03a02
– ident: e_1_2_16_83_1
  doi: 10.1111/j.1399‐3062.2008.00362.x
– ident: e_1_2_16_181_1
  doi: 10.1186/s13045‐022‐01275‐7
– ident: e_1_2_16_209_1
  doi: 10.1016/j.bbmt.2018.03.004
– ident: e_1_2_16_96_1
  doi: 10.1182/blood‐2011‐08‐371112
– ident: e_1_2_16_95_1
  doi: 10.1182/blood.V98.3.573
– ident: e_1_2_16_40_1
  doi: 10.1002/rmv.2375
– ident: e_1_2_16_124_1
  doi: 10.1016/j.cmi.2021.05.020
– ident: e_1_2_16_107_1
  doi: 10.1093/cid/ciy874
– ident: e_1_2_16_166_1
  doi: 10.3109/10428194.2015.1113279
– ident: e_1_2_16_11_1
  doi: 10.1093/cid/ciy792
– ident: e_1_2_16_27_1
  doi: 10.1007/s40291-022-00580-8
– ident: e_1_2_16_217_1
  doi: 10.1128/JVI.01631‐14
– ident: e_1_2_16_146_1
  doi: 10.3390/v13081665
– ident: e_1_2_16_45_1
  doi: 10.1016/j.bbmt.2012.11.139
– ident: e_1_2_16_63_1
  doi: 10.1093/infdis/jit832
– ident: e_1_2_16_62_1
  doi: 10.1093/infdis/jis610
– ident: e_1_2_16_169_1
  doi: 10.1182/blood-2006-12-060343
– ident: e_1_2_16_129_1
  doi: 10.1002/jmv.28471
– ident: e_1_2_16_159_1
  doi: 10.1111/tid.12054
– ident: e_1_2_16_157_1
  doi: 10.1016/j.jcv.2022.105152
– ident: e_1_2_16_221_1
  doi: 10.1093/infdis/jix203
– ident: e_1_2_16_188_1
  doi: 10.1093/cid/cix160
– ident: e_1_2_16_189_1
  doi: 10.1111/tid.12022
– ident: e_1_2_16_26_1
  doi: 10.1016/j.diagmicrobio.2015.10.025
– ident: e_1_2_16_175_1
  doi: 10.1111/j.1365-2141.2009.07654.x
– ident: e_1_2_16_156_1
  doi: 10.1086/425004
– ident: e_1_2_16_230_1
  doi: 10.1111/ejh.12094
– ident: e_1_2_16_77_1
  doi: 10.1016/j.bbmt.2018.11.022
– ident: e_1_2_16_185_1
  doi: 10.1016/j.ccell.2022.02.012
– ident: e_1_2_16_172_1
  doi: 10.3109/10428194.2015.1067699
– ident: e_1_2_16_69_1
  doi: 10.1093/jac/dkt111
– ident: e_1_2_16_206_1
  doi: 10.1056/NEJMc2031670
– ident: e_1_2_16_112_1
  doi: 10.1128/aac.00452-22
– volume-title: Specimen Collection Guidelines
  year: 2020
  ident: e_1_2_16_37_1
– ident: e_1_2_16_151_1
  doi: 10.1182/blood-2003-05-1425
– ident: e_1_2_16_106_1
  doi: 10.1111/tid.12111
– ident: e_1_2_16_4_1
  doi: 10.1182/blood‐2022‐167773
– ident: e_1_2_16_29_1
  doi: 10.1016/j.cmi.2017.11.018
– ident: e_1_2_16_86_1
  doi: 10.1038/s41409‐022‐01575‐z
– ident: e_1_2_16_41_1
  doi: 10.1128/cmr.00168-21
– ident: e_1_2_16_51_1
  doi: 10.1182/bloodadvances.2021004915
– ident: e_1_2_16_213_1
  doi: 10.3389/fimmu.2018.00678
– ident: e_1_2_16_227_1
  doi: 10.1093/infdis/jiab611
– ident: e_1_2_16_123_1
  doi: 10.1007/s00134-021-06448-5
– ident: e_1_2_16_163_1
  doi: 10.1182/blood-2010-11-319186
– ident: e_1_2_16_111_1
  doi: 10.1016/S1473-3099(20)30004-9
– ident: e_1_2_16_102_1
  doi: 10.1097/QCO.0b013e3283480440
– year: 2022
  ident: e_1_2_16_183_1
  article-title: Breakthrough COVID‐19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey
  publication-title: Blood
– ident: e_1_2_16_179_1
  doi: 10.1111/tid.13792
– ident: e_1_2_16_31_1
  doi: 10.1093/jac/dkab245
– ident: e_1_2_16_173_1
  doi: 10.1007/s15010-012-0279-9
– ident: e_1_2_16_82_1
  doi: 10.1182/blood-2013-12-541359
– ident: e_1_2_16_200_1
  doi: 10.3324/haematol.2021.280407
– ident: e_1_2_16_223_1
  doi: 10.1111/tid.13602
– ident: e_1_2_16_94_1
  doi: 10.1016/j.ijid.2023.03.045
– ident: e_1_2_16_115_1
  doi: 10.1093/infdis/jiac135
– ident: e_1_2_16_71_1
  doi: 10.1093/ofid/ofy077
– ident: e_1_2_16_67_1
  doi: 10.1038/s41409‐022‐01790‐8
– ident: e_1_2_16_98_1
  doi: 10.1038/s41409‐018‐0386‐z
– ident: e_1_2_16_149_1
  doi: 10.1038/sj.bmt.1704359
– ident: e_1_2_16_161_1
  doi: 10.1016/S1473‐3099(18)30600‐5
– ident: e_1_2_16_34_1
  doi: 10.1128/spectrum.00503-22
– ident: e_1_2_16_164_1
  doi: 10.1016/j.bbmt.2010.09.014
SSID ssj0017949
Score 2.4283
SecondaryResourceType review_article
Snippet Before the COVID‐19 pandemic, common community‐acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well‐being of...
Before the COVID-19 pandemic, common community-acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well-being of...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e14117
SubjectTerms adenovirus
allogeneic stem cell transplantation
Allografts
community acquired respiratory virus (CARV)
COVID-19
COVID-19 - epidemiology
Hematopoietic Stem Cell Transplantation - adverse effects
Hematopoietic stem cells
human adenovirus
human bocavirus
human metapneumovirus
human parainfluenza virus
human seasonal coronavirus
Humans
influenza virus
Pandemics
Respiratory Tract Infections - epidemiology
respiratory virus
rhinovirus
SARS‐CoV‐2
Severe acute respiratory syndrome coronavirus 2
Stem cell transplantation
Stem cells
Transplantation
vaccines.VRS
Viral diseases
Viruses
Title Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Ftid.14117
https://www.ncbi.nlm.nih.gov/pubmed/37585370
https://www.proquest.com/docview/2899282375
https://www.proquest.com/docview/2852632826
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1399-3062
  dateEnd: 20241001
  omitProxy: true
  ssIdentifier: ssj0017949
  issn: 1398-2273
  databaseCode: ABDBF
  dateStart: 19990301
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 1398-2273
  databaseCode: DR2
  dateStart: 19990101
  customDbUrl:
  isFulltext: true
  eissn: 1399-3062
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017949
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA7iyYsPfK0vonjwsF3apmkSPYm6qAcPi8IehJKkqSxKFdt68OofN5M-XF8g3ko7Ja-ZzEwy8w1C-3EkFadaeyEz2oukNh5Xqe8JbpVzpiIqjAuQvYrPb6LLMR3PoKM2F6bGh-gO3EAy3H4NAi5VMSXk5SS1Yh4EkEkeEOquaEcddBTwmXDOlrCcYHV0gyoEUTzdn5910TcD87O96hTOcAHdtl2t40zuB1WpBvr1C4rjP8eyiOYbQxQf15yzhGZMvozeRh837_hl8lwVuI3Wygvs6oljuKm3XGcmGgMINIajf1w6jPQHWScy5Ye4wX3C1XTyTB93R3j4Tj4VfWzfY7vnAmUTjVCsoJvh2fXJudeUafA0oYR5ggRhzAhVlBgW6YDFQspUKWatOeVDvUDBspBnkTI85T5PNfPTlIciDLRkPCWraDZ_zM06wplgJpYy1lKxKOZacJppSiKmFdGGyR46aBcs0Q2GOZTSeEhaX8bOZOJmsof2OtKnGrjjJ6KtdtWTRnaLBFzQEDB8aA_tdp-t1MF8ytw8VkBDAeje-mY9tFZzS9cKAReMMN921q35780n1xen7mHj76SbaA4q3tfpkFtotnyuzLa1i0q14wTgHbSSC58
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4BPZRLS1UeS4G6VQ89EJTEcWwjLgiKlpZyQIvEBUW246BVVwGRhEOv_eN4nEehFKnqLUomcmLPeB6e-QbgU5ooLZgxQcytCRJlbCB0HgZSOOVc6IRJ6xNkT9PxefL1gl3MwV5fC9PiQwwBN5QMv1-jgGNA-oGU19PcyXkU8Xl4gedzKJaHZwN4FHKa9O6WdLzgtHSHK4R5PMOrj7XRExPzscXqVc7Ra7jsP7bNNPmx09R6x_z8A8fxf_9mCV51tijZb5nnDczZ8i38Ovt9-E7uprdNRfqErbIivqU4wcN6x3h2agjiQBOM_pPaw6TPVFvLVO6SDvqJNA_rZ7bJEMUjV-qm2ibuPnHbLlJ2CQnVMpwffZkcjIOuU0NgKKM8kDSKU06ZZtTyxEQ8lUrlWnNn0OkQWwZKXsSiSLQVuQhFbniY5yKWcWQUFzldgYXyurRrQArJbapUapTmSSqMFKwwjCbcaGosVyP43K9YZjoYc-ymMct6d8bNZOZncgQfB9KbFrvjb0Qb_bJnnfhWGXqhMcL4sBF8GB47wcP5VKW9bpCGIda9c89GsNqyyzAKRS-M8tB9rF_054fPJseH_mL930nfw8vx5PtJdnJ8-u0dLMbO7GqrIzdgob5t7KYzk2q95aXhHljpD7s
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3La9ZAEB9qBfFiKz762VZX8eChKUl2N7urJ7F-tCpFSgs9CGFfkQ9L-tEkPfTqP-7O5mHrA8RbSCbsa2ZnZnfmNwAvC6aN5NYmufA2Ydr6RBqXJkoG5VwZxpWPAbKHxf4J-3DKT1fgzZgL0-NDTAduKBlxv0YBX7rqmpC3CxfEPMvELbjNiuBdoUV0NGFHIaOp6G2pwApBSQ-wQhjGM_16Uxn9ZmHeNFijxpmvwZexr32gybfdrjW79uoXGMf_HMw63BssUfK2Z537sOLrB_D96OfVO7lcXHQNGcO16obEguIEr-oD2_mFJYgCTfDsn7QRJP1M95lM9WsyAD-R7nr2zA6ZzvDIV71sdkh4T8Kmi5RDOELzEE7m74_f7SdDnYbEUk5FomiWF4Jyw6kXzGaiUFo7Y0Qw50yKBQOVqHJZMeOlk6l0VqTOyVzlmdVCOvoIVuvz2m8AqZTwhdaF1UawQloleWU5ZcIaar3QM3g1LlhpBxBzrKVxVo7OTJjJMs7kDF5MpMseueNPRFvjqpeD8DYl-qA5gvjwGTyfPgexw_nUtT_vkIYj0n1wzmbwuOeWqRWKPhgVaehsXPO_N18eH-zFhyf_TvoM7nzem5efDg4_bsLdPNhcfWrkFqy2F53fDjZSa55GWfgBKOoOag
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Respiratory+virus+infections+after+allogeneic+stem+cell+transplantation%3A+Current+understanding%2C+knowledge+gaps%2C+and+recent+advances&rft.jtitle=Transplant+infectious+disease&rft.au=Pi%C3%B1ana%2C+Jose+L&rft.au=P%C3%A9rez%2C+Ariadna&rft.au=Chor%C3%A3o%2C+Pedro&rft.au=Guerreiro%2C+Manuel&rft.date=2023-11-01&rft.eissn=1399-3062&rft.volume=25+Suppl+1&rft.spage=e14117&rft_id=info:doi/10.1111%2Ftid.14117&rft_id=info%3Apmid%2F37585370&rft.externalDocID=37585370
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1398-2273&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1398-2273&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1398-2273&client=summon